News of Note—Emergent BioSolutions and GeoVax

newspaper
(Pixabay)

Here is some other vaccine news of note for the week:

> Emergent BioSolutions filed for an FDA emergency use authorization for its anthrax vaccine NuThrax. Release

> GeoVax teamed up with Enesi Pharma to develop vaccines on a needle-free delivery platform. Release

Free Amazon Webinar

Performing end to end real-world evidence generation in the cloud with traceability and transparency- a Sanofi journey

In this webinar you will hear about Sanofi’s journey and experience in building an industrialized big data & analytics platform in the cloud that handles billions of rows of RWD data with complete data traceability, security, and supports both traditional and advanced analytics for day to day evidence generation (RWE).

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.